ASX - By Stock
|
AN1 |
Re:
Ann: Company Update
|
|
Ozjin
|
149 |
38K |
10 |
15/05/20 |
15/05/20 |
ASX - By Stock
|
149
|
38K
|
10
|
|
ASX - By Stock
|
STK |
Re:
Ann: Consolidation/Split - AYR
|
|
Ozjin
|
7 |
5.2K |
4 |
14/05/20 |
14/05/20 |
ASX - By Stock
|
7
|
5.2K
|
4
|
|
ASX - By Stock
|
STK |
Re:
Ann: Consolidation/Split - AYR
|
|
Ozjin
|
7 |
5.2K |
4 |
14/05/20 |
14/05/20 |
ASX - By Stock
|
7
|
5.2K
|
4
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
Ozjin
|
1.2K |
409K |
0 |
09/05/20 |
09/05/20 |
ASX - By Stock
|
1.2K
|
409K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
Ozjin
|
1.2K |
409K |
0 |
08/05/20 |
08/05/20 |
ASX - By Stock
|
1.2K
|
409K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
Ozjin
|
1.2K |
409K |
4 |
08/05/20 |
08/05/20 |
ASX - By Stock
|
1.2K
|
409K
|
4
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Trading Halt
|
|
Ozjin
|
79 |
25K |
16 |
07/05/20 |
07/05/20 |
ASX - By Stock
|
79
|
25K
|
16
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
Ozjin
|
1.2K |
409K |
0 |
02/05/20 |
02/05/20 |
ASX - By Stock
|
1.2K
|
409K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
Ozjin
|
1.2K |
409K |
1 |
02/05/20 |
02/05/20 |
ASX - By Stock
|
1.2K
|
409K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
Ozjin
|
1.2K |
409K |
1 |
01/05/20 |
01/05/20 |
ASX - By Stock
|
1.2K
|
409K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
If no ann Thurs Maria should be sacked
|
|
Ozjin
|
86 |
24K |
1 |
01/05/20 |
01/05/20 |
ASX - By Stock
|
86
|
24K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
If no ann Thurs Maria should be sacked
|
|
Ozjin
|
86 |
24K |
1 |
01/05/20 |
01/05/20 |
ASX - By Stock
|
86
|
24K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
If no ann Thurs Maria should be sacked
|
|
Ozjin
|
86 |
24K |
5 |
01/05/20 |
01/05/20 |
ASX - By Stock
|
86
|
24K
|
5
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Security Purchase Plan
|
|
Ozjin
|
5 |
2.5K |
5 |
28/04/20 |
28/04/20 |
ASX - By Stock
|
5
|
2.5K
|
5
|
|
ASX - By Stock
|
AN1 |
Re:
WHO says no evidence shows that having coronavirus prevents a second infection
|
|
Ozjin
|
44 |
11K |
9 |
26/04/20 |
26/04/20 |
ASX - By Stock
|
44
|
11K
|
9
|
|
ASX - By Stock
|
AN1 |
Re:
China version QVC
|
|
Ozjin
|
7 |
1.4K |
4 |
25/04/20 |
25/04/20 |
ASX - By Stock
|
7
|
1.4K
|
4
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid's Alopecia Patent Allowed in Australia and Japan
|
|
Ozjin
|
27 |
7.0K |
2 |
25/04/20 |
25/04/20 |
ASX - By Stock
|
27
|
7.0K
|
2
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid's Alopecia Patent Allowed in Australia and Japan
|
|
Ozjin
|
27 |
7.0K |
4 |
25/04/20 |
25/04/20 |
ASX - By Stock
|
27
|
7.0K
|
4
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid's Alopecia Patent Allowed in Australia and Japan
|
|
Ozjin
|
27 |
7.0K |
6 |
25/04/20 |
25/04/20 |
ASX - By Stock
|
27
|
7.0K
|
6
|
|
ASX - By Stock
|
VFX |
Re:
Ann: 1st launches Telehealth and TelehealthClinics.com.au
|
|
Ozjin
|
224 |
62K |
5 |
20/04/20 |
20/04/20 |
ASX - By Stock
|
224
|
62K
|
5
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid's Shipment of SARS-CoV-2 Tests Received
|
|
Ozjin
|
394 |
122K |
1 |
20/04/20 |
20/04/20 |
ASX - By Stock
|
394
|
122K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid's Shipment of SARS-CoV-2 Tests Received
|
|
Ozjin
|
394 |
122K |
4 |
18/04/20 |
18/04/20 |
ASX - By Stock
|
394
|
122K
|
4
|
|
ASX - By Stock
|
AN1 |
Re:
Top 20 Shareholder Listing – End Q2 2020
|
|
Ozjin
|
20 |
5.3K |
0 |
16/04/20 |
16/04/20 |
ASX - By Stock
|
20
|
5.3K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Tomorrows Chart
|
|
Ozjin
|
32 |
9.6K |
7 |
16/04/20 |
16/04/20 |
ASX - By Stock
|
32
|
9.6K
|
7
|
|
ASX - By Stock
|
AN1 |
Re:
Top 20 Shareholder Listing – End Q2 2020
|
|
Ozjin
|
20 |
5.3K |
0 |
16/04/20 |
16/04/20 |
ASX - By Stock
|
20
|
5.3K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Top 20 Shareholder Listing – End Q2 2020
|
|
Ozjin
|
20 |
5.3K |
2 |
16/04/20 |
16/04/20 |
ASX - By Stock
|
20
|
5.3K
|
2
|
|
ASX - By Stock
|
AN1 |
Re:
Top 20 Shareholder Listing – End Q2 2020
|
|
Ozjin
|
20 |
5.3K |
3 |
16/04/20 |
16/04/20 |
ASX - By Stock
|
20
|
5.3K
|
3
|
|
ASX - By Stock
|
AN1 |
Re:
Top 20 Shareholder Listing – End Q2 2020
|
|
Ozjin
|
20 |
5.3K |
0 |
16/04/20 |
16/04/20 |
ASX - By Stock
|
20
|
5.3K
|
0
|
|
ASX - By Stock
|
AN1 |
Top 20 Shareholder Listing – End Q2 2020
|
|
Ozjin
|
20 |
5.3K |
5 |
15/04/20 |
15/04/20 |
ASX - By Stock
|
20
|
5.3K
|
5
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
Ozjin
|
1.2K |
409K |
1 |
13/04/20 |
13/04/20 |
ASX - By Stock
|
1.2K
|
409K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
Ozjin
|
1.2K |
409K |
3 |
12/04/20 |
12/04/20 |
ASX - By Stock
|
1.2K
|
409K
|
3
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
Ozjin
|
1.2K |
409K |
6 |
08/04/20 |
08/04/20 |
ASX - By Stock
|
1.2K
|
409K
|
6
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
Ozjin
|
1.2K |
409K |
2 |
08/04/20 |
08/04/20 |
ASX - By Stock
|
1.2K
|
409K
|
2
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
Ozjin
|
1.2K |
409K |
22 |
08/04/20 |
08/04/20 |
ASX - By Stock
|
1.2K
|
409K
|
22
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
Ozjin
|
1.2K |
409K |
5 |
08/04/20 |
08/04/20 |
ASX - By Stock
|
1.2K
|
409K
|
5
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
Ozjin
|
1.2K |
409K |
3 |
08/04/20 |
08/04/20 |
ASX - By Stock
|
1.2K
|
409K
|
3
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
Ozjin
|
1.2K |
409K |
3 |
08/04/20 |
08/04/20 |
ASX - By Stock
|
1.2K
|
409K
|
3
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
Ozjin
|
1.2K |
409K |
16 |
08/04/20 |
08/04/20 |
ASX - By Stock
|
1.2K
|
409K
|
16
|
|
ASX - By Stock
|
AN1 |
Re:
Cellmid Placement Deal Sheet
|
|
Ozjin
|
99 |
32K |
1 |
08/04/20 |
08/04/20 |
ASX - By Stock
|
99
|
32K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Cellmid Placement Deal Sheet
|
|
Ozjin
|
99 |
32K |
1 |
08/04/20 |
08/04/20 |
ASX - By Stock
|
99
|
32K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
Ozjin
|
1.2K |
409K |
1 |
08/04/20 |
08/04/20 |
ASX - By Stock
|
1.2K
|
409K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Promedical Fraudulent Misrepresentation - WondFo Statement
|
|
Ozjin
|
40 |
14K |
9 |
06/04/20 |
06/04/20 |
ASX - By Stock
|
40
|
14K
|
9
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Suspension from Official Quotation
|
|
Ozjin
|
94 |
28K |
4 |
06/04/20 |
06/04/20 |
ASX - By Stock
|
94
|
28K
|
4
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Trading Halt
|
|
Ozjin
|
463 |
150K |
11 |
05/04/20 |
05/04/20 |
ASX - By Stock
|
463
|
150K
|
11
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Trading Halt
|
|
Ozjin
|
463 |
150K |
9 |
04/04/20 |
04/04/20 |
ASX - By Stock
|
463
|
150K
|
9
|
|
ASX - By Stock
|
GSS |
Re:
Ann: Change in substantial holding
|
|
Ozjin
|
7 |
2.6K |
0 |
03/04/20 |
03/04/20 |
ASX - By Stock
|
7
|
2.6K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Trading Halt
|
|
Ozjin
|
463 |
150K |
4 |
03/04/20 |
03/04/20 |
ASX - By Stock
|
463
|
150K
|
4
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Trading Halt
|
|
Ozjin
|
463 |
150K |
14 |
03/04/20 |
03/04/20 |
ASX - By Stock
|
463
|
150K
|
14
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Trading Halt
|
|
Ozjin
|
463 |
150K |
0 |
03/04/20 |
03/04/20 |
ASX - By Stock
|
463
|
150K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Trading Halt
|
|
Ozjin
|
463 |
150K |
3 |
03/04/20 |
03/04/20 |
ASX - By Stock
|
463
|
150K
|
3
|
|